The Global Therapeutic Pet Robots Market is estimated to be valued at USD 1.46 Bn in 2025 and is expected to reach USD 4.68 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 18.1% from 2025 to 2032. This significant growth reflects rising adoption of robotic companions in healthcare and eldercare, driven by the increasing demand for non-pharmacological interventions and technological advancements in robotics.
A key market trend is the integration of AI and machine learning to enhance the interactivity and responsiveness of therapeutic pet robots, making them more effective in providing emotional support and therapy. Additionally, growing awareness about mental health and the benefits of pet robots among aging populations and healthcare institutions is fueling market expansion. The trend towards personalized therapeutic solutions and increasing investments by technology firms further underscore the promising outlook of this market.
|
Current Events |
Description and its Impact |
|
Advancements in AI & Emotional Robotics |
|
|
Rising Neurodegenerative and Chronic Diseases |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Based on robot type, robotic dogs form the biggest percentage of the worldwide therapeutic pets robot market, accounting for an estimated 52.1% in 2025 due to their intense emotional communication and extremely interactive features. Dogs have long been counted as good companions and have a special capability of forming emotional connections with human beings, and it is reflected in the robotic counterparts that passively replicate them.
The robotic dogs are set to imitate the behavior of real dogs, such as tail wagging, receptive barking and playful movements, which are meant to attract the user attention and ensure maximum therapeutic value of the robot. This resemblance to a pet dog has led to robotic dogs especially being useful to users who may want a company pet but find it difficult to keep a real one because of allergies or other physical restrictions.
In 2025, the dementia and Alzheimer’s disease segment is expected to account for the largest share of the global therapeutic pet robots market at 20.3%, driven by the growing demand for non-pharmacological interventions that help ease symptoms and improve patient well-being. The neurodegenerative disorders cause memory loss, confusion, and emotional discomfort, and caregivers and medical practitioners are interested in identifying therapeutic options that will not have any negative side effects but instead enhance the quality of life.
In April 2020, Florida Department of Elder Affairs gave 375 robotic pets from Ageless Innovation, a U.S.-based company specializing in interactive products for older adults to the seniors with Alzheimer’s and dementia, to reduce isolation during COVID-19. The lifelike companions helped improve mood and social connection, with support from the Association on Aging in New York to expand the effort.
By technology, sensor-based interactive systems hold the largest market share in the global therapeutic pet robots with an estimated 30.3% in 2025 due to the fact that they provide real-time, intuitive feedback that creates a degree of engagement with the user.
These systems include different sensors like touch, movement, audio and proximity sensors that help the robot sense the presence of human beings and their activities so as to produce naturalistic responses promoting a natural interactive response. The flexibility of sensor-based robots is critical in the therapeutic environment that encourages emotional well-being and mental activity through positive reinforcement in the form of interaction.

To learn more about this report, Download Free Sample
In North America, the dominance in the global therapeutic pet robots market with an estimated share of 39.3% in 2025 is driven by high investments in the field of robotics and artificial intelligence, and a high rate of adoption in a therapeutic and eldercare environment. The region has got favorable government policies that support innovation in healthcare technology and the aging population care initiatives that support the market development.
For example, in September 2020, Northern Illinois Hospice, a leading end-of-life care provider in the U.S., introduced a robotic golden puppy to comfort patients amid suspended in-person pet therapy due to COVID-19. The lifelike robotic dog, equipped with motion sensors, heartbeat, and voice response, was funded through the hospice’s Pet Peace of Mind donor program.
The fastest growing market in the therapeutic pet robots product with an estimated share of 24.5% in 2025 will be Asia Pacific, driven by the growing awareness about the eldercare solutions, the growing disposable income, and the modernization of the health care infrastructure in the countries such as Japan, China and South Korea.
The high rate of urbanization and rising ages among citizens are triggering a high demand of the companion robots that offer mental and emotional comfort as well as therapeutic care. The governments in this region are being more encouraging with the help of financial assistance and programs to incorporate technology in senior care.
The therapeutic pet robots market in the U.S. exhibits a high level of adoption because of the high-level healthcare centers and well-grounded consumerism of the therapeutic robotic assistance. Large companies, such as Intuition Robotics, have launched advanced AI-enabled pet robots to help older users, encouraging interaction and preventing loneliness. Due to the large investment in healthcare R&D in the country, and the positive health policy on elderly care, the innovation is sustained and therapeutic pet robots are available to meet the needs of a variety of patients.
For example, New York City Department for the Aging (DFTA), the largest agency for older adults in the U.S., joined the New York State Office for the Aging in a robotic pet pilot program to reduce loneliness and depression among seniors. The initiative distributed robotic cats and dogs from Ageless Innovation, known for its companion pets for dementia patients, to socially isolated older adults.
The market of therapeutic pet robots in Japan is highly technological and culturally open to the use of robotics in everyday activities. Aibo robotic pet by Sony has specifically had an impact on this market as it had the ability to provide both entertainment and therapeutic value, and in a country where the population is rapidly aging, this product is more than desirable in terms of companionship. Market growth is highly motivated by the aggressive policies implemented by the Japanese government to ensure that the country has robot friendly policies to deal with labor shortages and aging issues.
For example, Japan’s National Institute of Advanced Industrial Science and Technology (AIST), a pioneer in robotics and automation research, introduced PARO, an advanced therapeutic robot created to deliver the benefits of animal-assisted therapy in hospitals and long-term care facilities where live pets are impractical. Shaped like a baby harp seal, PARO helps reduce stress, improve relaxation, and promote social interaction among patients and caregivers.
The therapeutic pet robots market in China is advancing very fast because of an intersection of a rising number of elderly care and a focus on modernization of healthcare put across by the government. Home-based firms such as UBTECH Robotics are developing technological systems to support emotional therapy and companionship based on the interaction of robotic pets. The high manufacturing foundation and assistance of innovation-oriented startups in China create a favorable market growth and export potential in the region.
For example, in China, UBTECH Robotics, headquartered in Shenzhen, leads innovation in emotional therapy and companionship robots. Its humanoid and pet-like robots, such as Alpha Mini and Walker X, are increasingly used in healthcare settings for elderly interaction and cognitive stimulation.
Germany currently occupies a particularly large niche in the therapeutic pet robots market in Europe, which has the advantage of having a well-developed healthcare and a borrowing of the latest assistive technologies. Fraunhofer Institute and European operations of Hasbro are companies that are concerned with the combination of biomedical research and robot design to achieve therapeutic requirements. Enabling technologies Digital health and eldercare policies promote the use of therapeutic pet robots as supplementary care methods by the institutions and consumers.
For example, in Germany, the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) has developed assistive and therapeutic robotic systems such as Care-O-bot and Roberta, used in hospitals and senior care facilities to support patient well-being and staff efficiency.

To learn more about this report, Download Free Sample
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1.46 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 18.1% | 2032 Value Projection: | USD 4.68 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
PARO Robots U.S. Inc, Ageless Innovation LLC, Tombot Inc, Yukai Engineering Inc, Consequential Robotics Ltd, Sony Corporation, Vanguard Industries Inc, JustoCat AB, Groove X Inc, Hyodol Co Ltd, Furhat Robotics AB, SoftBank Robotics Corp, Panasonic Holdings Corporation, Embodied Inc, and Blue Frog Robotics |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Download Free Sample
The growing interest in mental health as an important part of the overall well-being has been a major driver in the ever-growing demand of therapeutic pet robots. Due to the decrease in societal stigma related to mental health, an increasing number of people and medical professionals are moving towards new technologies to find new ways of dealing with anxiety, depression, and loneliness. Therapeutic pet robots provide a special combination of companionship and emotional support without the duties and restrictions of living animals, and this makes them especially attractive to the various groups of the population such as the elderly, children, and people with disabilities.
In April 2022, a review published in the Journal of Medical Internet Research (JMIR) Mental Health highlighted how social robots are supporting mental health awareness and emotional well-being worldwide. Researchers from the University of Montreal examined 30 studies showing that robots like PARO, a therapeutic seal by Japan’s Intelligent System Co., Sony’s AIBO, a robotic dog, and SoftBank Robotics’ Pepper, a humanoid robot, help reduce loneliness, anxiety, and depression while improving engagement in dementia and autism care. These emotionally supportive robots are being increasingly adopted in hospitals and eldercare facilities to promote companionship and mental health awareness.
The market of global therapeutic pet robots is expected to grow very fast due to personalization, which is AI-driven, and remote monitoring. The technologies allow the robots to change their behavior and responses to the feelings and actions of users on the spot, enhancing interaction and treatment effectiveness. Remote monitoring also enables caregivers to monitor mental health and activity to assist in providing personalized care and early interventions.
In December 2024, Sony Corporation, a global tech innovator, showcased the rising popularity of its Aibo Robot Dog, an AI-powered pet offering emotional support and companionship through facial recognition and adaptive learning. It was featured by Moonpreneur, a U.S.-based edtech company promoting robotics.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients